Viewing Study NCT01865292


Ignite Creation Date: 2025-12-24 @ 3:42 PM
Ignite Modification Date: 2026-01-04 @ 5:21 AM
Study NCT ID: NCT01865292
Status: COMPLETED
Last Update Posted: 2015-10-19
First Post: 2013-05-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Comparing the Pharmacodynamics and Pharmacokinetics of Explorative Formulation of Insulin Degludec With Insulin Glargine in Subjects With Type 1 and Type 2 Diabetes
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes View
None Diabetes Mellitus, Type 1 View
None Diabetes Mellitus, Type 2 View
Keywords: